Synonyms: compound 53 [PMID 16420052]
Compound class:
Synthetic organic
Comment: PBD150 is a potent inhibitor of glutaminyl cyclase (QC), an enzyme which can modify the N-terminal glutamate residue of amyloid beta (Aβ) proteins to generate pyroglutamate-Aβ [2].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Buchholz M, Heiser U, Schilling S, Niestroj AJ, Zunkel K, Demuth HU. (2006)
The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship. J Med Chem, 49 (2): 664-77. [PMID:16420052] |
2. Cynis H, Scheel E, Saido TC, Schilling S, Demuth HU. (2008)
Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta. Biochemistry, 47 (28): 7405-13. [PMID:18570439] |
3. Nussbaum JM, Schilling S, Cynis H, Silva A, Swanson E, Wangsanut T, Tayler K, Wiltgen B, Hatami A, Rönicke R et al.. (2012)
Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature, 485 (7400): 651-5. [PMID:22660329] |